$CLSN - Bullish Momentum From Bounce

2019年10月9日

Celsion Corp . engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

SHORT INTEREST
168.36K 09/13/19

P/E Current
-2.69

P/E Ratio (with extraordinary items)
-5.04

Average Recommendation: BUY

Average Target Price: 7.50